MDL | MFCD00864683 |
---|---|
Molecular Weight | 283.35 |
Molecular Formula | C12H17N3O3S |
SMILES | O=C(NC(N)=N)C1=CC=C(C(C)C)C(S(=O)(C)=O)=C1 |
Cariporide (HOE-642) is a selective Na + /H + exchange inhibitor.
Cariporide significantly suppresses markers of cell death, such as TUNEL positivity and caspase-3 cleavage, at 8 or 16 hours. Cariporide remarkably suppresses cytosolic Na + and Ca 2+ accumulation. Cariporide prevents mitochondrial membrane potential loss induced by H 2+ O 2+ [1] . Cariporide (HOE-642) ameliorates myocardial ischemia/reperfusion injury, by the well-established reduction of cytosolic Ca 2+ in cardiac myocytes through inhibition of Na + /H + exchange [2] . Cariporide (HOE-642), has inhibitory effects on the degranulation of human platelets, the formation of platelet–leukocyte-aggregates, and the activation of the GPIIb/IIIa receptor (PAC-1) [3] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Intravenous administration of cariporide significantly decreases brain Na + uptake and reduces cerebral edema, brain swelling, and infarct volume [4] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : ≥ 100 mg/mL ( 352.92 mM )
* "≥" means soluble, but saturation unknown.
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 3.5292 mL | 17.6460 mL | 35.2920 mL |
5 mM | 0.7058 mL | 3.5292 mL | 7.0584 mL |
10 mM | 0.3529 mL | 1.7646 mL | 3.5292 mL |